TABLE 1. GLOBAL CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY, 2014-2022, ($MILLION)
TABLE 2. GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET, FOR, BY REGION, 2014-2022, ($MILLION)
TABLE 3. GLOBAL CANCER CYTOKINES & IMMUNOMODULATORS MARKET, BY REGION, 2014-2022, ($MILLION)
TABLE 4. GLOBAL OTHER CANCER IMMUNOTHERAPY MARKET, BY REGION, 2014-2022, ($MILLION)
TABLE 5. GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION, 2014-2022, ($MILLION)
TABLE 6. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR LUNG CANCER, BY REGION, 2014-2022, ($MILLION)
TABLE 7. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR BREAST CANCER, BY REGION, 2014-2022, ($MILLION)
TABLE 8. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR COLORECTAL CANCER, BY REGION, 2014-2022, ($MILLION)
TABLE 9. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR MELANOMA, BY REGION, 2014-2022, ($MILLION)
TABLE 10. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR PROSTATE CANCER, BY REGION, 2014-2022, ($MILLION)
TABLE 11. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR HEAD & NECK CANCER, BY REGION, 2014-2022, ($MILLION)
TABLE 12. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR OTHER CANCERS, BY REGION, 2014-2022, ($MILLION)
TABLE 13. GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END-USER, 2014-2022, ($MILLION)
TABLE 14. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR HOSPITALS, BY REGION, 2014-2022, ($MILLION)
TABLE 15. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR CANCER RESEARCH CENTRES, BY REGION, 2014-2022, ($MILLION)
TABLE 16. GLOBAL CANCER IMMUNOTHERAPY MARKET, FOR CLINICS, BY REGION, 2014-2022, ($MILLION)
TABLE 17. GLOBAL CANCER IMMUNOTHERAPY MARKET, BY REGION, 2014-2022, ($MILLION)
TABLE 18. CANCER IMMUNOTHERAPY MARKET, FOR NORTH AMERICA, BY COUNTRY, 2014-2022, ($MILLION)
TABLE 19. CANCER IMMUNOTHERAPY MARKET, FOR NORTH AMERICA, BY TECHNOLOGY, 2014-2022, ($MILLION)
TABLE 20. CANCER IMMUNOTHERAPY MARKET, FOR NORTH AMERICA, BY APPLICATION, 2014-2022, ($MILLION)
TABLE 21. CANCER IMMUNOTHERAPY MARKET, FOR NORTH AMERICA, BY END-USER, 2014-2022, ($MILLION)
TABLE 22. CANCER IMMUNOTHERAPY MARKET, FOR EUROPE, BY COUNTRY, 2014-2022, ($MILLION)
TABLE 23. CANCER IMMUNOTHERAPY MARKET, FOR EUROPE, BY TECHNOLOGY, 2014-2022, ($MILLION)
TABLE 24. CANCER IMMUNOTHERAPY MARKET, FOR EUROPE, BY APPLICATION, 2014-2022, ($MILLION)
TABLE 25. CANCER IMMUNOTHERAPY MARKET, FOR EUROPE, BY END-USER, 2014-2022, ($MILLION)
TABLE 26. CANCER IMMUNOTHERAPY MARKET, FOR ASIA-PACIFIC, BY COUNTRY, 2014-2022, ($MILLION)
TABLE 27. CANCER IMMUNOTHERAPY MARKET, FOR ASIA-PACIFIC, BY TECHNOLOGY, 2014-2022, ($MILLION)
TABLE 28. CANCER IMMUNOTHERAPY MARKET, FOR ASIA-PACIFIC, BY APPLICATION, 2014-2022, ($MILLION)
TABLE 29. CANCER IMMUNOTHERAPY MARKET, FOR ASIA-PACIFIC, BY END-USER, 2014-2022, ($MILLION)
TABLE 30. CANCER IMMUNOTHERAPY MARKET, FOR LAMEA, BY COUNTRY, 2014-2022, ($MILLION)
TABLE 31. CANCER IMMUNOTHERAPY MARKET, FOR LAMEA, BY TECHNOLOGY, 2014-2022, ($MILLION)
TABLE 32. CANCER IMMUNOTHERAPY MARKET, FOR LAMEA, BY APPLICATION, 2014-2022, ($MILLION)
TABLE 33. CANCER IMMUNOTHERAPY MARKET, FOR LAMEA, BY END-USER, 2014-2022, ($MILLION)
TABLE 34. AMGEN INC. - COMPANY SNAPSHOT
TABLE 35. ADVAXIS INC. - COMPANY SNAPSHOT
TABLE 36. MERCK & CO., INC. - COMPANY SNAPSHOT
TABLE 37. ELI LILLY AND COMPANY - COMPANY SNAPSHOT
TABLE 38. BRISTOL-MYERS SQUIBB COMPANY - COMPANY SNAPSHOT
TABLE 39. PFIZER INC. - COMPANY SNAPSHOT
TABLE 40. NOVARTIS AG - COMPANY SNAPSHOT
TABLE 41. BAYER AG - COMPANY SNAPSHOT
TABLE 42. IMMUNOMEDICS INC. - COMPANY SNAPSHOT
TABLE 43. ASTRAZENECA PLC. - COMPANY SNAPSHOT

LIST OF FIGURE

FIGURE 1.CANCER IMMUNOTHERAPY: MARKET SEGMENTSTION
FIGURE 2.TOP INVESTMENT POCKETS
FIGURE 3.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION,(2014 2016)
FIGURE 4.TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5.MARKET SHARE ANALYSIS OF CANCER IMMUNOTHERAPY, 2015
FIGURE 6.CANCER IMMUNOTHERAPY: MONOCLONAL ANTIBODIES MARKET, 2014-2022, ($MILLION)
FIGURE 7.CANCER IMMUNOTHERAPY: CYTOKINES & IMMUNOMODULATORS MARKET, 2014-2022, ($MILLION)
FIGURE 8.CANCER IMMUNOTHERAPY: OTHERS THERAPIES MARKET, 2014-2022, ($MILLION)
FIGURE 9.CANCER IMMUNOTHERAPY: LUNG CANCER MARKET, 2014-2022, ($MILLION)
FIGURE 10.CANCER IMMUNOTHERAPY: BREAST CANCER MARKET, 2014-2022, ($MILLION)
FIGURE 11.CANCER IMMUNOTHERAPY: COLORECTAL CANCER MARKET, 2014-2022, ($MILLION)
FIGURE 12.CANCER IMMUNOTHERAPY: MELANOMA MARKET, 2014-2022, ($MILLION)
FIGURE 13.CANCER IMMUNOTHERAPY: PROSTATE CANCER MARKET, 2014-2022, ($MILLION)
FIGURE 14.CANCER IMMUNOTHERAPY: HEAD & NECK CANCERMARKET, 2014-2022, ($MILLION)
FIGURE 15.CANCER IMMUNOTHERAPY: OTHER CANCERS MARKET, 2014-2022, ($MILLION)
FIGURE 16.CANCER IMMUNOTHERAPY: HOSPITALS MARKET, 2014-2022, ($MILLION)
FIGURE 17.CANCER IMMUNOTHERAPY: CANCER RESEARCH CENTRES MARKET, 2014-2022, ($MILLION)
FIGURE 18.CANCER IMMUNOTHERAPY: CLINICS MARKET, 2014-2022, ($MILLION)
FIGURE 19.CANCER IMMUNOTHERAPY: U.S. MARKET, 2014-2022, ($MILLION)
FIGURE 20.CANCER IMMUNOTHERAPY: CANADA MARKET, 2014-2022, ($MILLION)
FIGURE 21.CANCER IMMUNOTHERAPY: MEXICO MARKET, 2014-2022, ($MILLION)
FIGURE 22.CANCER IMMUNOTHERAPY: UK MARKET, 2014-2022, ($MILLION)
FIGURE 23.CANCER IMMUNOTHERAPY: GERMANY MARKET, 2014-2022, ($MILLION)
FIGURE 24.CANCER IMMUNOTHERAPY: FRANCE MARKET, 2014-2022, ($MILLION)
FIGURE 25.CANCER IMMUNOTHERAPY: SPAIN MARKET, 2014-2022, ($MILLION)
FIGURE 26.CANCER IMMUNOTHERAPY: ITALY MARKET, 2014-2022, ($MILLION)
FIGURE 27.CANCER IMMUNOTHERAPY: REST OF EUROPE MARKET, 2014-2022, ($MILLION)
FIGURE 28.CANCER IMMUNOTHERAPY: CHINA MARKET, 2014-2022, ($MILLION)
FIGURE 29.CANCER IMMUNOTHERAPY: JAPAN MARKET, 2014-2022, ($MILLION)
FIGURE 30.CANCER IMMUNOTHERAPY: INDIA MARKET, 2014-2022, ($MILLION)
FIGURE 31.CANCER IMMUNOTHERAPY: REST OF ASIA-PACIFIC MARKET, 2014-2022, ($MILLION)
FIGURE 32.CANCER IMMUNOTHERAPY: LATIN AMERICA MARKET, 2014-2022, ($MILLION)
FIGURE 33.CANCER IMMUNOTHERAPY: MIDDLE EAST MARKET, 2014-2022, ($MILLION)
FIGURE 34.CANCER IMMUNOTHERAPY: AFRICA MARKET, 2014-2022, ($MILLION)